Oxford BioTherapeutics (OBT) has entered a multi-year partnership with Roche to discover antibody-based therapeutics for ...
Work to create a platform for Oxford rail station has been delayed by ongoing efforts to get Botley Road reopened. Network Rail closed Botley Road at the rail bridge as part of a £161m scheme to ...
Oxford BioTherapeutics (OBT) has lined up another big pharma partner for its drug discovery platform, agreeing to work with Roche on the hunt for new antibody therapeutics for cancer in a deal worth ...
Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for ...